Literature DB >> 8361676

Age-related susceptibility to MPTP-induced neurotoxicity in mice.

S F Ali1, S N David, G D Newport.   

Abstract

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to cause neurotoxicity in rodents and nonhuman primates. In this study the ontogeny of MPTP-induced DA depletion and formation of reactive oxygen species (ROS) were evaluated in mouse striatum. C57/B6N mice were injected four times with 0 or 10 mg/kg MPTP (i.p.) at two-hour intervals on either postnatal day 23, at about 7 months of age, and at one year of age. Animals were sacrificed 1, 2, 4, 8, 12, 24, 48 and 72 hours after the last dose. Brains were rapidly removed and striata were dissected for neurochemical analysis. Dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were measured by HPLC/EC. ROS formation was measured by a fluorescence probe, 2',7'-dichlorofluorescein-diacetate (DCFH-DA). MPTP produced a slight but significant decrease of DA only 4 hours post dosing on PND 23. DOPAC and HVA levels decreased up to 4 and 8 hours post dosing respectively and returned to control values thereafter. At 7 months of age, MPTP produced a 50-65% decrease of DA and its metabolites (DOPAC and HVA) in striatum 24 hours post dosing. In one year old mice, MPTP produced an 80% decrease of DA and 60-80% decrease of DOPAC and HVA in striatum. In contrast, ROS formation in striatum was not significantly increased by MPTP treatment at any age but was decreased at 1 hour only in PND 23 and 7 month old mice. These studies suggest that MPTP-induced neurotoxicity is age-dependent in the mouse.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361676

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  17 in total

1.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  Distinct effects of ketamine and acetyl L-carnitine on the dopamine system in zebrafish.

Authors:  Bonnie L Robinson; Melanie Dumas; Elvis Cuevas; Qiang Gu; Merle G Paule; Syed F Ali; Jyotshna Kanungo
Journal:  Neurotoxicol Teratol       Date:  2016-02-16       Impact factor: 3.763

4.  MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.

Authors:  Bobby Thomas; Rainer von Coelln; Allen S Mandir; Daniel B Trinkaus; Mohamed H Farah; Kah Leong Lim; Noel Y Calingasan; M Flint Beal; Valina L Dawson; Ted M Dawson
Journal:  Neurobiol Dis       Date:  2007-01-25       Impact factor: 5.996

5.  Opposing effects of ketamine and acetyl L-carnitine on the serotonergic system of zebrafish.

Authors:  Bonnie L Robinson; Melanie Dumas; Merle G Paule; Syed F Ali; Jyotshna Kanungo
Journal:  Neurosci Lett       Date:  2015-09-10       Impact factor: 3.046

Review 6.  alpha-Synuclein: a therapeutic target for Parkinson's disease?

Authors:  Kathleen A Maguire-Zeiss
Journal:  Pharmacol Res       Date:  2008-09-16       Impact factor: 7.658

7.  Synuclein activates microglia in a model of Parkinson's disease.

Authors:  Xiaomin Su; Kathleen A Maguire-Zeiss; Rita Giuliano; Landa Prifti; Karthik Venkatesh; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2007-05-29       Impact factor: 4.673

8.  Drug-induced circling preference in rats. Correlation with monoamine levels.

Authors:  S F Ali; K J Kordsmeier; B Gough
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

9.  Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer.

Authors:  Ronald L Klein; Robert D Dayton; Cynthia G Diaczynsky; David B Wang
Journal:  Neurobiol Aging       Date:  2009-01-19       Impact factor: 4.673

Review 10.  Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals.

Authors:  Gary Ginsberg; Dale Hattis; Abel Russ; Babasaheb Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.